Nebula Research & Development LLC
- SEC CIK
- 0001792635
- Latest filing
- May 15, 2026
EGRX holding history
Eagle Pharmaceuticals, Inc. in every 13F filed by Nebula Research & Development LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
EGRX overviewAll 13F holders of EGRXFull Q1 2026 holdings
- Shares (Q4 2023)
- 0
- Sold out in Q4 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 2
- Since Q2 2023